These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33260974)

  • 1. The Emerging Role of CD24 in Cancer Theranostics-A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond.
    Kleinmanns K; Fosse V; Bjørge L; McCormack E
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
    Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma.
    Kleinmanns K; Bischof K; Anandan S; Popa M; Akslen LA; Fosse V; Karlsen IT; Gjertsen BT; Bjørge L; McCormack E
    EBioMedicine; 2020 Jun; 56():102782. PubMed ID: 32454401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.
    Ceppi L; Bardhan NM; Na Y; Siegel A; Rajan N; Fruscio R; Del Carmen MG; Belcher AM; Birrer MJ
    ACS Nano; 2019 May; 13(5):5356-5365. PubMed ID: 31009198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].
    Azaïs H; Frochot C; Grabarz A; Khodja Bach S; Colombeau L; Delhem N; Mordon S; Collinet P
    Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):190-196. PubMed ID: 28359805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Molecular Targets for Tumor-Specific Imaging of Epithelial Ovarian Cancer Metastases.
    Muynck LDAN; Gaarenstroom KN; Sier CFM; Duijvenvoorde MV; Bosse T; Mieog JSD; Kroon CD; Vahrmeijer AL; Peters ITA
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.
    Debie P; Vanhoeij M; Poortmans N; Puttemans J; Gillis K; Devoogdt N; Lahoutte T; Hernot S
    Mol Imaging Biol; 2018 Jun; 20(3):361-367. PubMed ID: 29090412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal image-guided surgery of HER2-positive breast cancer using [
    Deken MM; Bos DL; Tummers WSFJ; March TL; van de Velde CJH; Rijpkema M; Vahrmeijer AL
    EJNMMI Res; 2019 Nov; 9(1):98. PubMed ID: 31754913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
    Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.
    Derks YHW; Löwik DWPM; Sedelaar JPM; Gotthardt M; Boerman OC; Rijpkema M; Lütje S; Heskamp S
    Theranostics; 2019; 9(23):6824-6839. PubMed ID: 31660071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer.
    Song J; Zhang N; Zhang L; Yi H; Liu Y; Li Y; Li X; Wu M; Hao L; Yang Z; Wang Z
    Int J Nanomedicine; 2019; 14():2757-2772. PubMed ID: 31118609
    [No Abstract]   [Full Text] [Related]  

  • 15. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of CD24 as a new molecular marker in ovarian cancer.
    Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
    J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy.
    Oren R; Addadi Y; Narunsky Haziza L; Dafni H; Rotkopf R; Meir G; Fishman A; Neeman M
    Int J Cancer; 2016 Oct; 139(8):1788-98. PubMed ID: 27242346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer.
    Ashihara K; Terai Y; Tanaka T; Tanaka Y; Fujiwara S; Maeda K; Tunetoh S; Sasaki H; Hayashi M; Ohmichi M
    Oncol Lett; 2020 Mar; 19(3):1872-1880. PubMed ID: 32194682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection.
    Lee HJ; Ehlerding EB; Jiang D; Barnhart TE; Cao T; Wei W; Ferreira CA; Huang P; Engle JW; Cai W
    Am J Cancer Res; 2019; 9(7):1454-1468. PubMed ID: 31392081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.
    van Dam GM; Themelis G; Crane LM; Harlaar NJ; Pleijhuis RG; Kelder W; Sarantopoulos A; de Jong JS; Arts HJ; van der Zee AG; Bart J; Low PS; Ntziachristos V
    Nat Med; 2011 Sep; 17(10):1315-9. PubMed ID: 21926976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.